Concepedia
Statistics
Publications
14
Citations
760
H-Index
13
Active since
1985
Affiliations
Novartis (Switzerland)(Current)
Merrell University of Beauty Arts and Science
Novartis Institutes for BioMedical Research
Western Laboratories (United States)
Prototek (United States)
Ronald E. Esser is an author at Novartis (Switzerland) specializing in medicine, anti-inflammatory pharmacology, and inflammation.
Publications per year
1985–2009
Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2
Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology · 2005 · 123 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +13
Cysteine Proteinase Inhibitors Decrease Articular Cartilage and Bone Destruction in Chronic Inflammatory Arthritis
Ronald E. Esser, Richard A. Angelo, Mark D. Murphey et al. · Arthritis & Rheumatism · 1994 · 122 citations
Medicine, Clinical Sciences, Pharmacology +16
Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase‐2
Jonathan N. King, Janet Dawson, Ronald E. Esser et al. · Journal of Veterinary Pharmacology and Therapeutics · 2009 · 78 citations · Full text
Medicine, Pharmacology, Cellular Pharmacology +12
Reactivation of streptococcal cell wall‐induced arthritis by homologous and heterologous cell wall polymers
Ronald E. Esser, Stephen A. Stimpson, William J. Cromartie et al. · Arthritis & Rheumatism · 1985 · 75 citations
Medicine, Immunology, Microbiology +12
Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis.
J A Wolos, Kathleen Frondorf, Ronald E. Esser · The Journal of Immunology · 1993 · 57 citations · Full text
Medicine, Immunology, Pathology +9
1–5 of 14